Stage III/IV Melanoma
specificStage III includes: (Any T, N1, M0); (Any T, N2, M0); (Any T, N3, M0). N1: Metastasis in one lymph node. N2: Metastasis in two to three regional lymph nodes or intralymphatic regional metastasis without nodal metastases. N3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s).
14
Centers
0
Active Trials
$1M
Cancer Funding
Top Centers for Stage III/IV Melanoma(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 69.8 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 52.3 |
| 3 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive | 52.3 |
| 4 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 52.3 |
| 5 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 52.3 |
| 6 | UF Health Cancer InstituteGainesville, FL NCI Clinical | 52.3 |
| 7 | NCI Clinical | 52.3 |
| 8 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 52.3 |
| 9 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 52.3 |
| 10 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 52.3 |
| 11 | Boston University Cancer CenterBoston, MA | 52.3 |
| 12 | 52.3 | |
| 13 | Penn State Cancer InstituteHershey, PA | 52.3 |
| 14 | Princess Margaret Cancer CentreToronto, ON | 52.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →